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Tumor lysis syndrome TLS is commonly seen during the treatment of rapidly proliferating. However TLS
is rarely reported in Non-small cell Lung Cancer. This may because of low proliferative rate and chemo-
resistant nature of NSCLC. We are reporting a case of tumor lysis without concomitant syndrome in a
patient with adenocarcinoma of Lung.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Tumor lysis syndrome (TLS) is a well-recognized fatal compli-
cation seen during the treatment of the rapidly proliferating and
chemo-sensitive tumors such as lymphomas and leukemias [1,2],
but rarely seen with solid tumor like lung cancer. Tumor lysis
syndrome complicating chemotherapy for non-small cell lung
cancer is very rare and to date there have been only four such cases
that have been reported in literature [10e13].2. Case report
A 59-year old African American male former heavy smoker (40
pack years) with no signiﬁcant past medical history presented to
our hospital with non-productive cough and shortness of breath on
exertion of three months duration. He did not report any history of
hemoptysis, weight lost, night sweats or fever. His vitals were
stable and thorough physical examination did not reveal any(A. Chopra), cmarak@
ore.org (N.K. Alappan),
@nbhn.net (C. Shim).
r Ltd. Open access under CC BY-NC-NDabnormal ﬁndings. Chest X-ray (Fig.1) revealed collapse of the right
upper lobe (RUL). CT scan of the chest (Fig. 2A and B) showed a
4  3.7  4 cm3 mass with areas of calciﬁcation abutting and
compressing the right upper lobe bronchus with atelectasis of the
RUL. Flexible bronchoscopy revealed an endobronchial lesion
which completely occluded the right upper lobe bronchus and
partially occluded the bronchus intermedius. Endobronchial biopsy
and brushing taken from the mass was positive for a poorly
differentiated primary lung adenocarcinoma that stained positive
for AE1/AE3, CK 7, TTF1, CD45 and Napsin A. Test for EGFR mutation
was negative but tests for p53 and Ki-67 were positive. His hospital
stay was complicated by development of focal seizure and weak-
ness involving the right upper extremity. Magnetic resonance im-
aging (MRI) of brain revealed multiple ring enhancing lesions
consistent with brain metastasis. Positron emission tomography
showed increased uptake in right upper lobe and right hilar lymph
node but no evidence of metastasis elsewhere. He received 6 cycles
of combination chemotherapy consisting of carboplatin, paclitaxel
and bevacizumab; whole brain radiation was given for his brain
metastasis. Repeat CXR (Fig. 3) and CT scan (Fig. 4) after three
months of initiation of chemotherapy showed re-expansion of the
right upper lobe and replacement of the mass with large air ﬁlled
cystic space that communicated with right main stem bronchus
and bronchus intermedius. Repeat laboratory investigation
revealed WBC of 14,500 cell/ml, serum creatinine of 0.9 mg/dL,
serum potassium of 4.1 mEq/dL, serum calcium of 9.8 mg/dl, serum
phosphate 4 mEq/dL, serum uric acid level of 5.4 mg/dl (normal license.
Fig. 1. CXR: Frontal view showing RUL collapse (s sign of gold).
Fig. 3. CXR Re-expansion of the RUL.
A. Chopra et al. / Respiratory Medicine Case Reports 10 (2013) 34e36 35range 3.5e7.2 mg/Dl) and serum LDH level of 187 IU/L (71e200 IU/
L). This was consistent with complete lysis of the lung tumor
without the metabolic derangements of tumor lysis syndrome. He
was initially maintained on bevacizumab but later switched to
erlotinib (EGFR inhibitor) due to hemoptysis. Most recent CT scan
after 18months of chemotherapy (Fig. 5) showed a further decrease
in the size of the cystic lesion. Except for recurrent seizures he
continues to do well after almost 30 months of his diagnosis with
metastatic lung cancer.
3. Discussion
Tumor lysis syndrome results from lysis of the rapidly prolifer-
ating malignant cells after the administration of cytotoxic chemo-
therapy. The release of the cellular contents result in metabolic
derangements such as hyper-uricemia, hyperkalemia, elevated LDH
levels, hyperphosphatemia, acute renal failure and hypocalcaemia
that characterize tumor lysis syndrome [2].Fig. 2. CT chest. 2A (left) coronal section 2B (cross-sectional image) of the chest showing RUL
collapse.TLS commonly occurs with hematological malignancies but is
rare with solid tumors due to relatively low proliferative index and
marginal response to chemotherapy. Solid tumors that are known
to cause TLS include breast carcinoma [3], medullo-blastoma [4],
ovarian cancer [5], rhabdomyosarcoma [6] and neuro-blastoma [7].
Typically these tumors are bulky with multiple metastatic foci and
generally are sensitive to initial chemotherapy. TLS rarely occurs
with small cell lung cancer [7e9] which is more chemo-sensitive,
but occurrence of TLS with NSCLC is extremely rare. This may be
due to low proliferative rate and chemo-resistance of NSCLC. There
have been only four case reports of TLS with NSCLC, and one of
them died of acute spontaneous tumor lysis syndrome without
chemotherapy.
Stage IV NSCLC is associated with poor prognosis. In patients
with good performance status chemotherapy improves survival by
only 4 months with 1-year survival of 10e20% and 5-year survival
of <5% [14]. Additionally expression of biomarker ki-67 in tumor
like our patient is associated with poor outcome [15].mass abutting right upper lobe bronchus and right main stem causing right upper lobe
Fig. 4. CT chest showing large air ﬁlled cyst communicating with right main stem
bronchus.
Fig. 5. CT chest: Cyst is smaller in size.
A. Chopra et al. / Respiratory Medicine Case Reports 10 (2013) 34e3636In this case report we describe a unique case of lung cancer with
complete lysis of the tumor resulting from chemotherapy leaving a
large cystic lesion in the lung. He did not have metabolic de-
rangements to suggest TLS. The possible explanation for the
absence of TLS despite complete lysis of the tumor is that the size of
the tumor was not large and bulky enough to cause the syndrome.
However it is still possible that he might have had milder form of
the TLS which was missed due to absence of symptoms. To our
knowledge, this is the ﬁrst case of lung cancer with complete lysis
of the tumor without tumor lysis syndrome.
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